Patents by Inventor Andrew Dannenberg

Andrew Dannenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060263887
    Abstract: Abstract of the Disclosure The invention provides a method of, and a kit for, assessing a pulmonary abnormality in a human by providing a standard that relates a degree of pulmonary abnormality with a level of a prostaglandin E2 metabolite, determining the level of the prostaglandin E2 metabolite in a human, and comparing the level determined in the human to the standard whereby the pulmonary abnormality in the human is assessed.
    Type: Application
    Filed: May 17, 2005
    Publication date: November 23, 2006
    Applicant: Cornell Research Foundation, Inc.
    Inventor: Andrew Dannenberg
  • Publication number: 20060199819
    Abstract: The present invention provides new methods for inhibiting the activity of the enzyme cycloxygenase-2 (or COX-2). Inhibitors of COX-2 are known to be useful anti-inflammatory, analgesic and anti-angiogenic agents. The compounds in the present case are heterocyclic substituted 4-aminoglutarimides. Methods of using the compounds to inhibit prostaglandin synthesis are claimed.
    Type: Application
    Filed: May 4, 2006
    Publication date: September 7, 2006
    Inventors: Andrew Dannenberg, George Muller
  • Publication number: 20050031537
    Abstract: Selective inhibitors of COX-2 and selective inhibitors of COX-1 are screened for COX protein independent therapeutic activity. Compounds passing screening testing are indicated for treatment of those having or at risk for cancer, Alzheimer's disease and atherosclerosis.
    Type: Application
    Filed: July 9, 2003
    Publication date: February 10, 2005
    Inventors: Andrew Dannenberg, Kotha Subbaramaiah